Recent session action on shares of Cameco Corporation (NYSE:CCJ) puts the stock on today's active list. After $-0.11 actual earnings per share reported by Cameco Corp for the previous quarter, Wall Street now forecasts -236.36 % EPS growth. The company has an average rating of Hold and an average price target of $15.22.
Saskatchewan-based Cameco's third-quarter uranium sales volume fell 1 percent to 9.2 million pounds, and its average realized price for the metal fell 26 per cent to $41.66 per pound. In terms of recent volatility, the average for the month is 2.60% and 1.58% for the past week.
A number of research firms have weighed in on CCJ. Cameco Corporation's revenue for the quarter was up 3.2% on a year-over-year basis. Frontier Investment Mgmt Co. acquired a new position in Cameco Corporation during the 2nd quarter worth approximately $2,325,000.
Cameco posted 3.1 million pounds of uranium produced for this year's quarter, compared to 5.9 million pounds this time in 2016. CSFB reduced their price target on shares of Cameco Corp from C$13.50 to C$10.00 in a research report on Tuesday, July 18th. Cameco Corporation's payout ratio is -1,066.31%. Jarislowsky Fraser Ltd now owns 17,180,015 shares of the company's stock valued at $250,539,000 after buying an additional 293,494 shares during the period. Cameco Corp (NYSE:CCJ) has a market cap of $3.53 Billion and the number of outstanding shares have been calculated 397.27 Million.
Cameco (CCJ -9.7%) plunges after reporting an unexpected Q3 loss and a 27% Y/Y revenue decline, and cutting its full-year production outlook. HRT Financial LLC bought a new position in Cameco Corporation in the 2nd quarter worth $129,000.
Cameco Corporation (NYSE:CCJ) last issued its quarterly earnings results on Wednesday, November 2nd. Cameco Corporation had a negative net margin of 0.75% and a positive return on equity of 2.59%. Equities research analysts anticipate that Cameco Corp will post $0.18 EPS for the current year. Creative Planning raised its holdings in Cameco Corporation by 55.3% in the 2nd quarter. The Manufacturers Life Insurance Company boosted its holdings in shares of Cameco Corporation by 1.2% in the 2nd quarter. If you are reading this piece on another publication, it was stolen and republished in violation of United States & worldwide copyright and trademark law.
Heading into the earnings release, covering analysts have a consensus target price of $11.77 on Cameco Corporation shares. For the past 5 days of trading, the stock has seen a move of -2.31%. The Firm is primarily engaged in the exploration for and the development, mining, refining, conversion, fabrication and trading of uranium for sale as fuel for generating electricity in nuclear power reactors in Canada and other countries. The legal version of this piece of content can be accessed at https://www.dispatchtribunal.com/2017/10/25/cameco-corporation-ccj-given-average-recommendation-of-hold-by-brokerages.html. The Firm operates through three divisions: uranium, fuel services and NUKEM.